Minseung Kim

The paper builds a normalized synovial transcriptomic compendium of RA patients to identify gene expression signatures predictive of treatment response to infliximab and other drugs.

This paper develops a network-based model to identify drug repositioning targets for RA, finding that anti-diabetic agents have similar network signatures to DMARDs and predicting synergistic drug combinations.

The paper investigates cross-stress responses in Escherichia coli by analyzing genetic and transcriptional changes under multiple abiotic stresses, identifying cases of protection and vulnerability.